Assess the safety and efficacy of amitriptyline, pregabalin, and gabapentin for the management of neuropathic pain at Ayaan Institute of Medical Sciences

Abstract

Background: The most prevalent neuropathic pain disorders now being treated with tricyclic
antidepressants (TCA), gabapentin, and pregabalin are considered first-line treatments for
neuropathic pain. Many times, current neuropathic pain treatments are ineffective. Despite
the availability of substantial information from numerous recommendations, there is still a
significant degree of heterogeneity in treatment patterns. According to recent statistics from
the Indian market, the guidelines actually advocate the use (selling) of medications including
amitriptyline, pregabalin, and gabapentin.